The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 09, 2018
Filed:
Mar. 14, 2014
Applicant:
Panoptica, Inc., Bernardsville, NJ (US);
Inventors:
David P. Bingaman, Weatherford, TX (US);
Paul G. Chaney, Mount Arlington, NJ (US);
Martin B. Wax, Far Hills, NJ (US);
Assignee:
PanOptica, Inc., Bernardsville, NJ (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/80 (2006.01); A61K 31/425 (2006.01); A61K 31/427 (2006.01); A61K 9/00 (2006.01); A61K 47/40 (2006.01); A61K 9/08 (2006.01); A61K 47/18 (2017.01);
U.S. Cl.
CPC ...
A61K 31/427 (2013.01); A61K 9/0048 (2013.01); A61K 9/08 (2013.01); A61K 47/18 (2013.01); A61K 47/186 (2013.01); A61K 47/40 (2013.01);
Abstract
The present invention relates to topical formulations comprising a compound of the following formula: for treating ocular neovascularization. The Compound-I is present in a solution or a suspension in about 0.005% to about 5.0% w/v, such that the solution or suspension delivers the compound at the posterior segment of the eye for inhibiting VEGF in the retina and/or the choroid.